Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JP Vasilakos
Intratumoral Immunotherapy With the TLR7/8 Agonist 3m-052
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
The TLR7/8 Agonist R848 Remodels Tumor and Host Responses to Promote Survival in Pancreatic Cancer
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Addressing the Adult Soft Tissue Sarcoma Microenvironment With Intratumoral Immunotherapy
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia
Cancer Research
Cancer Research
Oncology
Protective T Cell Immunity in Mice Following Protein-Tlr7/8 Agonist-Conjugate Immunization Requires Aggregation, Type I IFN, and Multiple DC Subsets
Journal of Clinical Investigation
Medicine
TLR9 Agonist, but Not TLR7/8, Functions as an Adjuvant to Diminish FI-RSV Vaccine-Enhanced Disease, While Either Agonist Used as Therapy During Primary RSV Infection Increases Disease Severity
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity
The TLR7 Agonist Imiquimod as an Adjuvant for Radiotherapy-Elicited in Situ Vaccination Against Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
RNA‐Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators
Small
Materials Science
Nanoscience
Engineering
Biomaterials
Medicine
Biotechnology
Nanotechnology
Chemistry
TLR7/8 Adjuvant Overcomes Newborn Hyporesponsiveness to Pneumococcal Conjugate Vaccine at Birth
JCI insight
Medicine
